Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain – a survey of pain medicine physicians in Canada, Germany and Israel.
Source: Eur J Pain 2023 Jan 24; . doi: 10.1002/ejp.2082Authors: Lauff S, Petzke F, Brill S, Schouten L, Fitzcharles M-A, Pereira JX, Häuser W
A major concern with cannabis-based medicines and medical cannabis (CbM) is the risk of abuse and dependence. The face validity of the International Classification of Diseases (ICD-10) criteria for cannabis dependence in patients prescribed CbM for chronic pain has not been assessed.
Pubmed ID: http://www.ncbi.nlm.nih.gov/pubmed/36692097?dopt=Abstract